查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1784061

蛋白質A樹脂的全球市場

Protein A Resins
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 202 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球蛋白質 A 樹脂市場規模將達到 23 億美元

全球蛋白A樹脂市場規模預計在2024年為17億美元，預計到2030年將達到23億美元，2024年至2030年的複合年成長率為5.5%。重組蛋白A是本報告分析的細分市場之一，預計其複合年成長率為4.4%，到分析期結束時規模將達到13億美元。天然蛋白A細分市場在分析期間的複合年成長率預計為7.1%。

美國市場規模估計為 4.39 億美元，中國市場預計複合年成長率為 5.5%

美國蛋白A樹脂市場規模預計2024年達到4.39億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到3.725億美元，在分析期間（2024-2030年）的複合年成長率為5.5%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為5.0%和4.8%。在歐洲，預計德國的複合年成長率約為4.6%。

全球蛋白A樹脂市場－主要趨勢與促進因素摘要

為什麼蛋白質 A 樹脂在生物製藥製造中很重要？

Protein A 樹脂主要用於親和層析法以精製單株抗體 (mAb)，已成為生物製藥生產的重要組成部分。對生物生技藥品（包括用於治療癌症、自體免疫疾病和感染疾病的單株抗體療法）的不斷成長的需求推動了 Protein A 樹脂在藥物研究和藥物開發中的廣泛應用。這種樹脂能高效地捕獲和精製具有高特異性的抗體，確保生物治療藥物的品質和功效。隨著生物製藥產業的不斷擴張，各公司正在投資先進的精製技術，以提高藥物產量、降低生產成本並滿足嚴格的監管標準。此外，生物相似藥和個人化醫療的興起進一步推動了對高效抗體精製方案的需求，使 Protein A 樹脂成為現代生物加工中必不可少的工具。

哪些挑戰影響了蛋白質 A 樹脂市場的成長？

儘管在生物製藥精製中發揮關鍵作用，蛋白 A 樹脂市場仍面臨著影響其可擴展性和成本效益的若干挑戰。一個主要問題是蛋白 A 樹脂生產高成本，這顯著增加了單株抗體製造的總費用。樹脂柱的有限壽命也是一個挑戰，頻繁更換會增加營運成本和廢棄物管理問題。此外，生物製藥製造中法規遵循的複雜性需要嚴格的驗證過程，進一步減緩了新樹脂技術的採用。離子交換層析法和混合模式層析法等替代精製技術的興起也為尋求經濟高效和擴充性選項的公司帶來了競爭。應對這些挑戰需要再生性、製程最佳化，以及開發大規模生物製藥生產中具有成本效益的蛋白 A 樹脂替代品。

層析法和生物加工技術的創新如何提高蛋白質 A 樹脂的效率？

層析法和生物加工技術的進步顯著提高了 Protein A 樹脂的效率和永續性。高容量耐鹼性樹脂的開發延長了精製管柱的壽命，減少了樹脂更換頻率並降低了生產成本。連續層析法整合也徹底改變了抗體精製，使生物製藥製造商能夠提高製程效率、最大限度地減少樹脂使用量並提高產品產量。此外，重組 Protein A 配體的進步提高了樹脂的穩定性和選擇性，提高了精製效率，同時最大限度地減少了目標分子的損失。奈米技術在樹脂開發中的應用進一步最佳化了結合能力並縮短了精製時間，使抗體生產更具成本效益。隨著生物製藥公司不斷擴大生產規模和最佳化精製工作流程，Protein A 樹脂的創新在提高生技藥品生產的成本效益和永續性發揮關鍵作用。

推動蛋白質 A 樹脂市場成長的因素是什麼？

蛋白 A 樹脂市場的成長受到多種因素的推動，包括對單株抗體療法的需求不斷成長、對生物製藥製造的投資不斷增加以及層析法技術的進步。個人化醫療和生物目標的擴展推動了對高純度抗體生產的需求，進一步推動了市場需求。癌症和自體免疫疾病等慢性疾病的增加也加速了生技藥品的採用，需要高效的精製技術。此外，隨著製藥公司尋求具有成本效益的精製解決方案，生物相似藥和生物改良藥的出現為蛋白 A 樹脂製造商創造了新的機會。向一次性生物製程系統和層析法工作流程的轉變進一步提高了抗體精製的可擴展性和效率。隨著生物製藥創新的不斷發展，預計蛋白 A 樹脂市場將經歷持續成長，因為它支持下一代生物製藥的開發。

部分

類型（重組蛋白A、天然蛋白A）、材料類型（瓊脂糖基蛋白A、玻璃/二氧化矽基蛋白A、有機聚合物基蛋白A）、應用（抗體精製、免疫沉澱）、最終用途（製藥/生物技術最終用途、學術研究最終用途、其他最終用途）

受訪公司範例

  • Abcam plc
  • Agarose Bead Technologies
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation（Cytiva）
  • Expedeon Ltd.
  • GenScript Biotech Corporation
  • JSR Life Sciences
  • Kaneka Corporation
  • Merck KGaA
  • Novasep
  • Orochem Technologies Inc.
  • PerkinElmer, Inc.
  • Prometic Life Sciences Inc.
  • Purolite Life Sciences
  • Repligen Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience
  • WR Grace & Co.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP32713

Global Protein A Resins Market to Reach US$2.3 Billion by 2030

The global market for Protein A Resins estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Recombinant Protein A, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Natural Protein A segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$439.0 Million While China is Forecast to Grow at 5.5% CAGR

The Protein A Resins market in the U.S. is estimated at US$439.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$372.5 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.0% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Protein A Resin Market - Key Trends & Drivers Summarized

Why Is Protein A Resin Crucial in Biopharmaceutical Manufacturing?

Protein A resin has become an essential component in biopharmaceutical production, primarily used in affinity chromatography for the purification of monoclonal antibodies (mAbs). The increasing demand for biologics, including monoclonal antibody therapies for cancer, autoimmune diseases, and infectious diseases, has driven the widespread adoption of Protein A resin in pharmaceutical research and drug development. This resin is highly effective in capturing and purifying antibodies with high specificity, ensuring the quality and efficacy of biotherapeutic drugs. As the biopharmaceutical industry continues to expand, companies are investing in advanced purification techniques to enhance drug yield, reduce production costs, and meet stringent regulatory standards. Additionally, the rise of biosimilars and personalized medicine has further increased the demand for efficient antibody purification solutions, making Protein A resin an indispensable tool in modern bioprocessing.

What Challenges Are Impacting the Growth of the Protein A Resin Market?

Despite its critical role in biopharmaceutical purification, the Protein A resin market faces several challenges that impact its scalability and cost efficiency. One of the primary concerns is the high cost associated with Protein A resin production, which significantly adds to the overall expense of monoclonal antibody manufacturing. The limited lifespan of resin columns also presents a challenge, as frequent replacements increase operational costs and waste management concerns. Additionally, the complexity of regulatory compliance in biopharmaceutical manufacturing requires rigorous validation processes, further delaying the adoption of newer resin technologies. The emergence of alternative purification techniques, such as ion-exchange chromatography and mixed-mode chromatography, is also creating competition, as companies explore cost-effective and scalable options. Addressing these challenges requires continued advancements in resin reusability, process optimization, and the development of cost-effective alternatives to Protein A resin in large-scale bioproduction.

How Are Innovations in Chromatography and Bioprocessing Enhancing Protein A Resin Efficiency?

Advancements in chromatography and bioprocessing technology are significantly improving the efficiency and sustainability of Protein A resin. The development of high-capacity and alkali-resistant resins is extending the longevity of purification columns, reducing the frequency of resin replacement and lowering production costs. The integration of continuous chromatography is also revolutionizing antibody purification, enabling biopharmaceutical manufacturers to enhance process efficiency, minimize resin usage, and improve product yield. Additionally, advancements in recombinant Protein A ligands are enhancing resin stability and selectivity, ensuring higher purification efficiency with minimal loss of target molecules. The use of nanotechnology in resin development is further optimizing binding capacity and reducing purification time, making antibody production more cost-effective. As biopharmaceutical companies continue to scale up production and optimize purification workflows, innovations in Protein A resin are playing a crucial role in improving the cost-effectiveness and sustainability of biologics manufacturing.

What Is Driving the Growth of the Protein A Resin Market?

The growth in the Protein A resin market is driven by several factors, including the rising demand for monoclonal antibody therapeutics, increasing investment in biopharmaceutical manufacturing, and advancements in chromatography technologies. The expansion of personalized medicine and targeted biologic therapies is fueling the need for high-purity antibody production, further driving market demand. The increasing prevalence of chronic diseases, such as cancer and autoimmune disorders, has also accelerated the adoption of biologics, necessitating efficient purification techniques. Additionally, the emergence of biosimilars and biobetters is creating new opportunities for Protein A resin manufacturers, as pharmaceutical companies seek cost-effective purification solutions. The shift toward single-use bioprocessing systems and automation in chromatography workflows is further enhancing the scalability and efficiency of antibody purification. As biopharmaceutical innovation continues to evolve, the Protein A resin market is expected to witness sustained growth, supporting the development of next-generation biologic therapies.

SCOPE OF STUDY:

The report analyzes the Protein A Resins market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Recombinant Protein A, Natural Protein A); Material Type (Agarose-based Protein A, Glass / Silica-based Protein A, Organic Polymer-based Protein A); Application (Antibody Purification Application, Immunoprecipitation Application); End-Use (Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abcam plc
  • Agarose Bead Technologies
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Cytiva)
  • Expedeon Ltd.
  • GenScript Biotech Corporation
  • JSR Life Sciences
  • Kaneka Corporation
  • Merck KGaA
  • Novasep
  • Orochem Technologies Inc.
  • PerkinElmer, Inc.
  • Prometic Life Sciences Inc.
  • Purolite Life Sciences
  • Repligen Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience
  • W. R. Grace & Co.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Protein A Resins - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Demand for Monoclonal Antibody Therapeutics Throws the Spotlight on High-Capacity Protein A Resin Solutions
    • Expansion of Biopharmaceutical Manufacturing Pipelines Drives Adoption of Affinity Chromatography Purification Technologies
    • Growth in Biosimilar and Biologics Production Strengthens Business Case for Cost-Effective and Scalable Resin Platforms
    • Advancements in Ligand Engineering and Immobilization Techniques Propel Development of Next-Generation Protein A Resins
    • Increased Emphasis on Process Efficiency and High Binding Capacity Spurs Innovation in High-Flow, High-Density Resin Formats
    • Integration of Protein A Resins into Continuous Bioprocessing Workflows Accelerates Demand for Robust, Reusable Materials
    • Emergence of Single-Use and Prepacked Column Systems Expands Accessibility for Small-Scale and Modular Bioproduction
    • Focus on Downstream Bottleneck Reduction in Biologic Manufacturing Drives Process Optimization Using Protein A Resin
    • Rising Pressure to Lower Cost of Goods Sold (COGS) Strengthens Demand for Long-Life and High-Cycle-Count Resin Variants
    • Growing Investment in Antibody-Drug Conjugates and Novel mAbs Boosts Market for Specialized Resin Solutions
    • Expansion of Contract Development and Manufacturing Organizations (CDMOs) Fuels Large-Volume Resin Procurement
    • Regulatory Emphasis on Purity, Consistency, and Leachables Drives Quality Control in Resin Manufacturing and Validation
    • Adoption of High-Throughput Screening Technologies Enhances Resin Selection and Scale-Up in Process Development
    • Increasing Demand for Flexible and Multi-Product Bioproduction Facilities Spurs Custom Resin Design and Versatility
    • Collaborations Between Resin Manufacturers and Biopharma Innovators Strengthen Co-Development of Application-Specific Resins
    • Focus on Green Chemistry and Sustainable Resin Manufacturing Drives Innovation in Biodegradable and Solvent-Free Processes
    • Rising Use of Protein A Resin in Academic and Government Research Expands Market Beyond Commercial Therapeutics
    • Challenges in Resin Reusability and Cleanability Create Opportunities for Disposable Resin Formats and Smart Monitoring Tools
    • Technological Integration of Smart Sensors and AI in Downstream Processing Drives Real-Time Resin Performance Analytics
    • Growth in Emerging Markets and Regional Biomanufacturing Hubs Expands Global Demand for Localized Resin Supply Chains
    • Surge in Pandemic-Driven Vaccine and Antibody Development Programs Accelerates Strategic Stockpiling of Protein A Resin
    • Standardization of Process Analytical Technology (PAT) in Biomanufacturing Enhances Predictive Control Over Resin Utilization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Protein A Resins Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Protein A Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Protein A Resins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Recombinant Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Recombinant Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Natural Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Natural Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Agarose-based Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Agarose-based Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Glass / Silica-based Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Glass / Silica-based Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Organic Polymer-based Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Organic Polymer-based Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Antibody Purification Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Antibody Purification Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Immunoprecipitation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Immunoprecipitation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • JAPAN
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • CHINA
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • EUROPE
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Protein A Resins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Protein A Resins by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • FRANCE
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 66: France Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 70: France Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • GERMANY
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 76: Germany Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Germany 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • ITALY
    • TABLE 82: Italy Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Italy 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 84: Italy Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Italy 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 90: UK Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: UK 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 94: UK Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of Europe 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Asia-Pacific 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Asia-Pacific 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 114: Rest of World Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of World 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of World 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030

IV. COMPETITION